4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with 17-alpha-hydroxyprogesterone in 1 studies
| Studies (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Trials (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Recent Studies (post-2010) (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Studies (17-alpha-hydroxyprogesterone) | Trials (17-alpha-hydroxyprogesterone) | Recent Studies (post-2010) (17-alpha-hydroxyprogesterone) |
|---|---|---|---|---|---|
| 42 | 0 | 9 | 2,148 | 145 | 434 |
| Protein | Taxonomy | 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine (IC50) | 17-alpha-hydroxyprogesterone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.051 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.051 | |
| Adenosine receptor A3 | Homo sapiens (human) | 4.73 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.3 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.739 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.051 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.051 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.051 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 3.157 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.905 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |